Alberto Garaventa
Overview
Explore the profile of Alberto Garaventa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
163
Citations
3265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tosto V, Prefumo F, Scala C, Tallone R, Garaventa A, Podesta M, et al.
Int J Gynaecol Obstet
. 2025 Feb;
PMID: 39981691
Ewing sarcoma is an aggressive, rare bone and soft tissue malignancy, often affecting the long bones and pelvis. A woman was diagnosed with Ewing sarcoma of the left pelvis at...
2.
Morini M, Barco S, Ardito M, Cafaro A, Pigliasco F, Rossi L, et al.
Oncologist
. 2025 Feb;
30(2).
PMID: 39945419
Background: GD2 ganglioside, a known specific marker for neuroblastoma (NB), exists in different lipoforms, including C18 and C20, which are distinguished by the length of their fatty acid chains. C18...
3.
Biondi M, Barco S, Cangelosi D, Cafaro A, Morini M, Pigliasco F, et al.
Clin Chim Acta
. 2024 Oct;
565:120005.
PMID: 39419313
Background: Risk assessment at diagnosis is crucial for neuroblastoma (NB) in order to address patients at high-risk to the most timely and appropriate treatments. 3-O-methyldopa (3-OMD), a direct metabolite of...
4.
Capasso M, Brignole C, Lasorsa V, Bensa V, Cantalupo S, Sebastiani E, et al.
J Transl Med
. 2024 Feb;
22(1):151.
PMID: 38351008
Background: Neuroblastoma (NB) represents the most frequent and aggressive form of extracranial solid tumor of infants. Although the overall survival of patients with NB has improved in the last years,...
5.
Valles-Colomer M, Manghi P, Cumbo F, Masetti G, Armanini F, Asnicar F, et al.
EBioMedicine
. 2023 Dec;
99:104917.
PMID: 38104504
Background: Neuroblastoma is the most frequent extracranial solid tumour in children, accounting for ∼15% of deaths due to cancer in childhood. The most common clinical presentation are abdominal tumours. An...
6.
Fiz F, Cirone A, Righi S, Massollo M, Amoroso L, Bottoni G, et al.
Pediatr Blood Cancer
. 2023 Dec;
71(3):e30806.
PMID: 38082548
Background: I-metaiodobenzylguanidine ( I-mIBG) effectiveness in children with metastasised neuroblastoma (NB) is linked to the effective dose absorbed by the target; a target of 4 Gy whole-body dose threshold has...
7.
Morini M, Raggi F, Bartolucci M, Petretto A, Ardito M, Rossi C, et al.
Cells
. 2023 Nov;
12(21).
PMID: 37947594
Neuroblastoma (NB) is the most common extracranial solid tumor during infancy, causing up to 10% of mortality in children; thus, identifying novel early and accurate diagnostic and prognostic biomarkers is...
8.
Chicco D, Haupt R, Garaventa A, Uva P, Luksch R, Cangelosi D
Eur J Cancer
. 2023 Sep;
193:113291.
PMID: 37708628
Objective: Seek new candidate prognostic markers for neuroblastoma outcome, relapse or progression. Materials And Methods: In this multicentre and retrospective study, Random Forests coupled with recursive feature elimination techniques were...
9.
Pastorino F, Capasso M, Brignole C, Lasorsa V, Bensa V, Perri P, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765519
Neuroblastoma (NB) is the most common extracranial solid tumor in childhood. Patients with relapsed/refractory disease have a poor prognosis, and additional therapeutic options are needed. Mutations and amplifications in the...
10.
Romano F, Madia F, De Marco P, Ognibene M, Guerrisi S, Scala M, et al.
Birth Defects Res
. 2022 Nov;
114(20):1440-1448.
PMID: 36345927
Segmental overgrowth syndromes include a group of clinical entities, all characterized by the abundant proliferation of tissues or organs in association with vascular abnormalities. These syndromes show a wide spectrum...